← FDA DRUG APPROVALS

FDA NDA · NDA012947

ARTANE

Sponsor: LEDERLE

APPLICATION
NDA012947
TYPE
NDA
ORIGINAL APPROVAL
1962-04-18
LATEST ACTION
1993-06-15
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ARTANEDiscontinued
TRIHEXYPHENIDYL HYDROCHLORIDE 5MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1993-06-15Manufacturing (CMC) · Supplement 22 · standardAP
1987-07-24Labeling · Supplement 19 · standardAP
1987-02-26Labeling · Supplement 20 · standardAP
1984-06-26Manufacturing (CMC) · Supplement 18 · standardAP
1982-07-22Manufacturing (CMC) · Supplement 17 · standardAP
1977-02-08Efficacy · Supplement 11 · standardAP
1962-04-18Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →